(Q43776098)

English

Immunotherapy with an oral Alternaria extract in childhood asthma. Clinical safety and efficacy and effects on in vivo and in vitro parameters

scientific article published in November 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Immunotherapy with an oral Alternaria extract in childhood asthma. Clinical safety and efficacy and effects on in vivo and in vitro parameters (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

based on heuristic

inferred from title

author name string

Criado Molina A

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Guerra Pasadas F

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Daza Muñoz JC

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Moreno Aguilar C

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Almeda Llamas E

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Muñoz Gomariz E

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Font Ugalde P

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Alonso Díaz C

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Germán Cárdenas M

9

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sánchez Guijo P

10

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Allergologia et Immunopathologia

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

319-330

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-86

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Symptoms of bronchial hyperreactivity and asthma in relation to environmental factors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Postgraduate course presentations. Mold-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on Alternaria allergens *1IV. Biologic activity of a purified Alternaria fraction (Alt-1)

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Purification and characterisation of a major allergen of Alternaria alternata

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A major antigen of Alternaria alternata with potential for safe and effective immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis and immunotherapy of mould allergy. V. Clinical efficacy and side effects of immunotherapy with Cladosporium herbarum

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Late and immediate systemic-allergic reactions to inhalant allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Fatalities from immunotherapy (IT) and skin testing (ST)

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Anaphylaxis in immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The safety of allergenic immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Survey of fatalities from skin testing and immunotherapy 1985-1989.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotherapy: a one-year prospective study to evaluate risk factors of systemic reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic reactions to immunotherapy: the American Academy of Otolaryngic Allergy morbidity and mortality survey

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic reactions from allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Accuracy of the death certificate in a population-based study of asthmatic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Local immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of three variations of the radioallergosorbent test-inhibition assay for measuring allergenic activity of grass pollen extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Standardization of Alternaria alternata: extraction and quantification of alt a 1 by using an mAb-based 2-site binding assay

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. A double blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and immunological effects of oral immunotherapy with a standardized birch pollen extract

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral immunotherapy in birch pollen hay fever

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral immunotherapy with short ragweed extract in a novel encapsulated preparation: a double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral administration of grass pollen to hay fever patients. An efficacy study in oral hyposensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

High dose grass pollen tablets used for hyposensitization in hay fever patients. A one-year double blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific IgE, IgG, and IgA antibody response to oral immunotherapy in birch pollinosis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis and immunotherapy of mould allergy. VII. IgG subclass response and relation to the clinical efficacy of immunotherapy with Cladosporium

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2802%2979147-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0301-0546(02)79147-7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

release_xjinsledrbfqrhornlsjdsczae

1 reference

https://api.fatcat.wiki/v0/release/xjinsledrbfqrhornlsjdsczae

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43776098&oldid=2103227227"